| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy has considered most of the risks associated with the services it provides at a distance. But these have not been documented in a clear manner along with the medicines it supplies. So the pharmacy is unable to demonstrate all of the risks have been considered and have suitable measures in place to reduce these risks. |
Risk assessments completed for medicines/treatments |
02/09/2025 | 31/07/2025 |
| 2.2 | Some members of the pharmacy team are trained dispensers or registered pharmacy technicians. But some of the team members have been working in the pharmacy without undertaking an appropriate training course for their role. So they may not have the underpinning knowledge or skills required for the work they complete. |
Member of staff has been enrolled onto Buttercups course. |
02/09/2025 | 31/07/2025 |
| 4.2 | The pharmacy provides a remote weight loss service which includes a video consultation with the pharmacist. But the pharmacist independent prescriber solely relies upon the video to verify the weight information provided. So the pharmacy may not always be able to show how robust this method is for people who have a borderline BMI. |
All future weight loss patients will be required to provide pictures of a scale showing their weight as well as the video call, regardless of their BMI. |
02/09/2025 | 31/07/2025 |
| 4.2 | The pharmacy offers a testosterone replacement therapy service following two blood tests, in line with guidance. But the pharmacy is unable to demonstrate how it meets the guidance in relation to completing a physical examination, which is important to identify potential alternative diagnoses. |
Testosterone replacement therapy service suspended immediately. Patients referred elsewhere to continue treatment. |
02/09/2025 | 31/07/2025 |
| 4.2 | The pharmacy offers medicines as part of its testosterone replacement therapy to counteract some of the associated side effects. But the use of these medicines is unlicensed, and it does not identify the additional counselling advice which should be provided to people so they can make an informed choice about their care. |
Testosterone replacement therapy service suspended immediately. Patients referred elsewhere to continue treatment. |
02/09/2025 | 31/07/2025 |
Pharmacy inspections
Inspection reports and learning from inspections